Stock EMBC EMBECTA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Embecta Corp.

Equities

EMBC

US29082K1051

Real-time Estimate Cboe BZX
Other stock markets
 02:25:20 2024-05-28 pm EDT 		5-day change 1st Jan Change
13.33 USD +1.52% Intraday chart for Embecta Corp. -2.92% -29.79%
May. 16 Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
May. 09 Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup DJ

Evolution of the average Target Price on Embecta Corp.

Price target over the last 5 years

History of analyst recommendation changes

72cbc1ae7f99818.jp2XJKTjHgrpBWl9lu6XjvaGunnE95946P1wWuMp8X4.3vDCFs6iLke5dUQn0IL86prwlxKg2tAQpconHddPlzy2q9Nt9dFtPLNnXQ~50b7e23c11aa2f8571e2705f13a31d9f

Analyst Recommendations on Embecta Corp.

Morgan Stanley Adjusts Price Target on to $16 From $15, Maintains Underweight Rating MT
Morgan Stanley Adjusts Price Target on Embecta to $15 From $16, Maintains Underweight Rating MT
BofA Trims Price Target on Embecta to $17 From $25, Keeps Underperform Rating MT
Morgan Stanley Trims Price Target on Embecta to $16 From $19, Maintains Underweight Rating MT
Morgan Stanley Adjusts Price Target on Embecta to $19 From $29, Maintains Underweight Rating MT
Morgan Stanley Downgrades Embecta to Underweight From Equalweight, Price Target is $28 MT
Morgan Stanley Adjusts Price Target on Embecta to $31 From $33, Maintains Equal-Weight Rating MT
Morgan Stanley Adjusts Price Target on Embecta Corp. to $33 From $36, Reiterates Equalweight Rating MT
BTIG Initiates Embecta at Neutral MT
Morgan Stanley Adjusts Price Target on Embecta to $36 From $33, Keeps Equalweight Rating MT
Morgan Stanley Initiates Embecta at Equalweight with $33 Price Target MT
BofA Securities Initiates Embecta at Underperform with $25 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
13.13 USD
Average target price
15 USD
Spread / Average Target
+14.24%
High Price Target
17 USD
Spread / Highest target
+29.47%
Low Price Target
13 USD
Spread / Lowest Target
-0.99%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Embecta Corp.

Morgan Stanley
BofA Securities
BTIG

Ratings for Embecta Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EMBC Stock
  4. Consensus Embecta Corp.